Since its founding, GILUPI has been supported financially by four Private-Equity-Fonds (AURELIA Private Equity, BC Brandenburg Capital, High-Tech Gründerfonds und Sparkassen Unternehmensbeteiligungsgesellschaft). Further capital was generated by sponsorships and investments made by private persons such as experienced entrepreneurs, executives and employees. They have realized the potential of GILUPI’s unique technology from the beginning and financed as well as supported the growth of the company with strategic advice. Recently, Hebei Viroad Biotechnology Co. Ltd. from the People’s Republic of China joints the list of GILUPI investors. Viroad will enable access of the GILUPI technology to the growing Asian markets.